THE ANTIADRENERGIC EFFECT OF ADENOSINE AND ITS BLOCKADE BY PERTUSSIS TOXIN - A COMPARATIVE-STUDY IN MYOCYTES ISOLATED FROM GUINEA-PIG, RAT AND FAILING HUMAN HEARTS

被引:45
作者
BROWN, LA
HUMPHREY, SM
HARDING, SE
机构
[1] Department of Cardiac Medicine, National Heart/Lung Institute, London SW3 6LY, Dovehouse Street
关键词
D O I
10.1111/j.1476-5381.1990.tb12734.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. In intact ventricular preparations, adenosine has been shown to reduce the β-adrenoceptor-induced increase in contraction (the anti-adrenergic effect). In the present study we have investigated this effect of adenosine on isolated ventricular myocytes from failing human heart and normal guinea-pig and rat heart. 2. Adenosine in the absence of β-adrenoceptor-mediated stimulation had no effect on contraction in human and guinea-pig myocytes but produced a variable effect in rat myocytes. 3. 8-Cyclopentyl 1,3-dipropylxanthine (CPX), a selective A1-receptor antagonist, antagonised the anti-adrenergic effect of adenosine in guinea-pig myocytes. 4. The anti-adrenergic effect of adenosine was greater in guinea-pig than rat myocytes and even more pronounced in cells isolated from failing human heart. 5. Pertussis toxin-pretreatment at 35°C of guinea-pig and human myocytes abolished the anti-adrenergic effect of adenosine. Longer exposure to higher concentrations of pertussis toxin was required for complete abolition in human compared to guinea-pig cells. 6. These results support the suggestion that the adenosine receptors mediating the anti-adrenergic effect of adenosine are of the A1 subtype and are coupled to the inhibitory guanine nucleotide binding protein, G(i)/G(o). 7. Pertussis toxin pretreatment increased the sensitivity of guinea-pig myocytes to isoprenaline in the absence of adenosine; the EC50 value was decreased by a factor of 10. This suggests that G(i) may exert a tonic inhibitory effect on the β-adrenoceptor/adenylate cyclase interaction in normal myocardium.
引用
收藏
页码:484 / 488
页数:5
相关论文
共 24 条
  • [1] ACTIONS OF ADENOSINE AND ISOPROTERENOL ON ISOLATED MAMMALIAN VENTRICULAR MYOCYTES
    BELARDINELLI, L
    ISENBERG, G
    [J]. CIRCULATION RESEARCH, 1983, 53 (03) : 287 - 297
  • [2] COUPLING OF ADENOSINE RECEPTORS TO A PERTUSSIS TOXIN-SENSITIVE G-PROTEIN IN THE HUMAN-HEART
    BOHM, M
    GIERSCHIK, P
    UNGERER, M
    ERDMANN, E
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1989, 172 (4-5): : 407 - 411
  • [3] ROLE OF GUANINE NUCLEOTIDE-BINDING PROTEIN IN THE REGULATION BY ADENOSINE OF CARDIAC POTASSIUM CONDUCTANCE AND FORCE OF CONTRACTION - EVALUATION WITH PERTUSSIS TOXIN
    BOHM, M
    BRUCKNER, R
    NEUMANN, J
    SCHMITZ, W
    SCHOLZ, H
    STARBATTY, J
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1986, 332 (04) : 403 - 405
  • [4] CHARACTERIZATION OF A1 ADENOSINE RECEPTORS IN ATRIAL AND VENTRICULAR MYOCARDIUM FROM DISEASED HUMAN HEARTS
    BOHM, M
    PIESKE, B
    UNGERER, M
    ERDMANN, E
    [J]. CIRCULATION RESEARCH, 1989, 65 (05) : 1201 - 1211
  • [5] BOHM M, 1988, EUR HEART J, V9, P844
  • [6] DECREASED CATECHOLAMINE SENSITIVITY AND BETA-ADRENERGIC-RECEPTOR DENSITY IN FAILING HUMAN HEARTS
    BRISTOW, MR
    GINSBURG, R
    MINOBE, W
    CUBICCIOTTI, RS
    SAGEMAN, WS
    LURIE, K
    BILLINGHAM, ME
    HARRISON, DC
    STINSON, EB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (04) : 205 - 211
  • [7] REDUCED POSITIVE INOTROPIC EFFECTS IN DISEASED HUMAN VENTRICULAR MYOCARDIUM
    BROWN, L
    LORENZ, B
    ERDMANN, E
    [J]. CARDIOVASCULAR RESEARCH, 1986, 20 (07) : 516 - 520
  • [8] BINDING OF THE A1-SELECTIVE ADENOSINE ANTAGONIST 8-CYCLOPENTYL-1,3-DIPROPYLXANTHINE TO RAT-BRAIN MEMBRANES
    BRUNS, RF
    FERGUS, JH
    BADGER, EW
    BRISTOL, JA
    SANTAY, LA
    HARTMAN, JD
    HAYS, SJ
    HUANG, CC
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1987, 335 (01) : 59 - 63
  • [9] APPARENT AFFINITY OF 1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE FOR ADENOSINE-A1 AND ADENOSINE-A2 RECEPTORS IN ISOLATED-TISSUES FROM GUINEA-PIGS
    COLLIS, MG
    STOGGALL, SM
    MARTIN, FM
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1989, 97 (04) : 1274 - 1278